Antimicrobial susceptibility of Francisella noatunensis subsp. noatunensis strains isolated from Atlantic cod Gadus morhua in Norway

Diseases of Aquatic Organisms

Volumn 98, Issue 1, 2012, Pages 57-62

  Isachsen, Cecilie H ^a   Vågnes, Øivind ^b   Jakobsen, Ragnhild Aa ^c   Samuelsen, Ole B ^a  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b NORWEGIAN VETERINARY INSTITUTE   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Atlantic cod; Francisella noatunensis subsp; Noatunensis; Susceptibility

Indexed keywords

ANTIMICROBIAL ACTIVITY; BACTERIAL DISEASE; DISEASE PREVALENCE; GADOID FISHERY; INHIBITOR; MARICULTURE;

NORWAY;

FRANCISELLA; GADUS MORHUA;

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; ATLANTIC COD; CLASSIFICATION; DRUG EFFECT; FISH DISEASE; FRANCISELLA; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NORWAY;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FISH DISEASES; FRANCISELLA; GADUS MORHUA; GRAM-NEGATIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; NORWAY;

EID: 84861117216     PISSN: 01775103     EISSN: 16161580     Source Type: Journal    
DOI: 10.3354/dao02430     Document Type: Article

References (41)

1. Alderman DJ, Smith P (2001) Development of draft protocols of standard reference methods for antimicrobial agent susceptibility testing of bacteria associated with fish diseases. Aquaculture 196: 211-243 (Pubitemid 32382909)
2. Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48: 5-16
3. Birkbeck TH, Feist SW, Verner-Jeffreys DW (2011) Franci - sella infections in fish and shellfish. J Fish Dis 34: 173-187
4. Bohle H, Tapia E, Martìnez A, Rozas M, Figueroa A, Bustos P (2009) Francisella philomiragia, bacteria asociada con altas mortalidades en salmons del Atlantico (Salmo salar) cultivados en balsas-jaulas en el lago Llanquihue. Arch Med Vet 41: 237-244 (in Spanish)
5. Bowser PR, Kosoff RE, Chen CY, Wooster GA and others (2009) Florfenicol residues in Nile tilapia after 10-d dosing in feed: effect of fish size. J Aquat Anim Health 21: 14-17
6. Chern RS, Chao CB (1994) Outbreaks of a disease caused by rickettsia-like organisms in cultured tilapias in Taiwan. Fish Pathol 29: 61-71
7. Colquhoun DJ, Duodu S (2011) Francisella infections in farmed and wild aquatic organisms. Vet Res 42: 47-62
8. Elema MO, Hoff KA, Kristensen HG (1996) Bioavailability of oxytetracycline from medicated feed administered to Atlantic salmon (Salmo salar L.) in seawater. Aquaculture 143: 7-14 (Pubitemid 26311337)
9. Fairgrieve WT, Masada CL, McAuley WC, Peterson ME, Myers MS, Strom MS (2005) Accumulation and clearance of orally administered erythromycin and its derivative, azithromycin, in juvenile fall Chinook salmon Oncorhynchus tshawytscha. Dis Aquat Org 64: 99-106 (Pubitemid 40689692)
10. Feng JB, Jia XP (2009) Single dose pharmacokinetic study of florfenicol in tilapia (Oreochromis niloticus × O. aureus) held in freshwater at 22°C. Aquaculture 289: 129-133
11. García del Blanco N, Gutiérrez-Martín CB, De la Puente- Redondo VA, Rodrígues Ferri EF (2004) In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents. Res Vet Sci 76: 195-198
12. Hansen MK, Horsberg TE (2000) Single-dose pharmacokinetics of flumequine in cod (Gadus morhua) and goldsinny wrasse (Ctenolabrus rupestris). J Vet Pharmacol Ther 23: 163-168
13. Hjeltnes B (2009) Farmed fish health report 2008. National Veterinary Institute, Oslo
14. Horsberg TE, Martinsen B, Sandersen K, Zernichow L (1997) Potentiated sulphonamides: in vitro inhibitory effects and pharmacokinetic properties in Atlantic salmon in seawater. J Aquat Anim Health 9: 203-210 (Pubitemid 28050165)
15. Johansson A, Urich SK, Chu MC, Sjöstedt A, Tärnvik A (2002) In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis. Scand J Infect Dis 34: 327-330 (Pubitemid 34746249)
16. Kosoff RE, Chen CY, Wooster GA, Getchell RG and others (2009) Florfenicol residues in three species of fish after 10-d dosing in feed. J Aquat Anim Health 21: 8-13
17. Lewin CS, Hastings TS (1990) In vitro activities of oxolinic acid, ciprofloxacin and norfloxacin against Aeromonas salmonicida. J Fish Dis 13: 377-384
18. Mauel MJ, Miller DL, Styer E, Pouder DB, Yanong RP, Goodwin AE, Schwedler TE (2005) Occurrence of piscirickettsiosis- like syndrome in tilapia in the continental United States. J Vet Diagn Invest 17: 601-605 (Pubitemid 41666914)
19. Maurin M, Mersali NF, Raoult D (2000) Bactericidal activities of antibiotics against intracellular Francisella tularensis. Antimicrob Agents Chemother 44: 3428-3431 (Pubitemid 33009505)
20. Mikalsen J (2008) Diagnosis and characterisation of in tra - cellular Gram-negative pathogens of marine and sal mo nid fish. Thesis, Norwegian School of Veterinary Science, Oslo
21. Nylund A, Ottem KF, Watanabe K, Karlsbakk E, Krossøy B (2006) Francisella sp. (family Francisellaceae) causing mortality in Norwegian cod (Gadus morhua) farming. Arch Microbiol 185: 383-392
22. Olsen AB, Mikalsen J, Rode M, Alfjorden A and others (2006) A novel systemic granulomatous inflammatory disease in farmed Atlantic cod, associated with a bacterium belonging to the genus Francisella. J Fish Dis 29: 307-311 (Pubitemid 43742605)
23. Ostland VE, Stannard JA, Creek JJ, Hedrick RP, Ferguson HW, Calberg JM, Westerman ME (2006) Aquatic Francisella- like bacterium associated with mortality of intensively cultured hybrid striped bass Morone chrysops × M. saxatilis. Dis Aquat Org 72: 135-145 (Pubitemid 44799857)
24. Ottem KF, Nylund A, Karlsbakk E, Friis-Møller A, Krossøy B, Knappskog D (2007) New species in the genus Francisella (Gammaproteobacteria; Francisellaceae); Francisella piscida sp. nov. isolated from cod (Gadus morhua). Arch Microbiol 188: 547-550 (Pubitemid 47583440)
25. Ottem KF, Nylund A, Isaksen TE, Karlsbakk E, Bergh Ø (2008) Occurrence of Francisella piscicida in farmed and wild Atlantic cod, Gadus morhua L., in Norway. J Fish Dis 31: 525-534 (Pubitemid 351814302)
26. Rigos G, Nengas I, Tyrpenou AE, AlexisM, Troisi GM (2003) Pharmacokinetics and bioavailability of oxytetracycline in gilthead sea bream (Sparus aurata) after a single dose. Aquaculture 221: 75-83 (Pubitemid 36409061)
27. Rigos G, Tyrpenou AE, Nengas I, Alexis M, Athanassopoulou F, Troisi GM (2004a) Poor bioavailability of oxytetracycline in sharpsnout sea bream Diplodus puntazzo. Aquaculture 235: 489-497 (Pubitemid 38617264)
28. Rigos G, Nengas I, Alexis M, Athanassopoulou F (2004b) Bioavailability of oxytetracycline in sea bass, Dicentrarchus labrax L. J Fish Dis 27: 119-122 (Pubitemid 38319185)
29. Samuelsen OB (2006a) Multiple dose pharmacokinetic study of oxolinic acid in cod. Aquacult Int 14: 443-450 (Pubitemid 44490006)
30. Samuelsen OB (2006b) Absorption, tissue distribution, me - tabolism and excretion of ormetoprim and sulphadi - methoxine in cod after oral administration of Romet30. J Appl Ichthyology 22: 68-71 (Pubitemid 43733182)
31. Samuelsen OB, Bergh Ø (2004) Efficacy of orally administered florfenicol and oxolinic acid for the treatment of vibriosis in cod (Gadus morhua). Aquaculture 235: 27-35 (Pubitemid 38617232)
32. Samuelsen OB, Ervik A, Wennevik V (1995) Absorption, tissue distribution, metabolism and excretion of ormetoprim and sulphadimethoxine in Atlantic salmon (Salmo salar) after intravenous and oral administration of Romet. Xenobiotica 25: 1169-1180
33. Samuelsen OB, Bergh Ø, Ervik A (2003a) A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in cod, Gadus morhua L., held in sea water at 8°C and in vitro antibacterial activity of oxolinic acid against Vibrio anguillarum strains isolated from diseased cod. J Fish Dis 26: 339-347 (Pubitemid 36821342)
34. Samuelsen OB, Bergh Ø, Ervik A (2003b) Pharmacokinetics of florfenicol in cod Gadus morhua and in vitro antibacterial activity against Vibrio anguillarum. Dis Aquat Org 56: 127-133 (Pubitemid 37293071)
35. Shojaee AliAbadi F, Lees P (2000) Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. Int J Antimicrob Agents 14: 307-313 (Pubitemid 30224494)
36. Soto E, Endris RG, Hawke JP (2010) In vitro and in vivo efficacy of florfenicol for treatment of Francisella asiatica infection in Tilapia. Antimicrob Agents Chemother 54: 4664-4670
37. Soto E, GriffinM, Wiles J, Hawke JP (2012) Genetic analysis and antimicrobial susceptibility of Francisella noatunensis subsp. orientalis (syn. F. asiatica) isolated from fish. Vet Microbiol 154:107-412
38. Tomaso H, Al Dahouk S, Hofer E, Splettstoesser WD, Treu TM, Dierich MP, Neubauer H (2005) Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int J Antimicrob Agents 26: 279-284 (Pubitemid 41338654)
39. Urich SK, Petersen JM (2008) In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother 52: 2276-2278 (Pubitemid 351758579)
40. Vik-Mo FT, Bergh Ø, Samuelsen OB (2005) Efficacy of orally administrated flumequine in the treatment of vibriosis caused by Listonella anguillarum in Atlantic cod Gadus morhua. Dis Aquat Org 67: 87-92 (Pubitemid 41784269)
41. Wang Q, Liu Q, Li J (2004) Tissue distribution of oxytetracycline in perch (Lateolabras janopicus) and black seabream (Sparus macrocephalus) following oral administration. Aquaculture 237: 31-40 (Pubitemid 38893796)